Impact of deep brain stimulation on pharyngo-esophageal motility: a randomized cross-over study.

S Derrey, N Chastan, D Maltete, E Verin, P Dechelotte, R Lefaucheur, F Proust, P Freger, A M Leroi, J Weber, G Gourcerol

Journal: Neurogastroenterology and motility 2016;27(9):1214-22

PMID: 26053217

Abstract

BACKGROUND

Bilateral subthalamic nucleus (STN) stimulation is used to alleviate Parkinson's disease (PD) motor symptoms. Recently, it has been shown that this therapeutic also increased gut cholinergic contractions. We therefore investigated the effect of STN stimulation on esophageal motility in an interventional randomized study.

METHODS

Sixteen humans PD patients (4 women, 12 men; age: 62.4 ± 9.3-years old) who underwent STN stimulation for at least 6 months were randomly evaluated with either stimulator turned OFF then ON, or inversely. Esophageal high resolution manometry was performed at the end of each ON and OFF period, with a 5 min resting period followed by ten swallows of 5 mL.

KEY RESULTS

During the ON, an increase in the distal contractility index was found (OFF: 1750 ± 629 vs ON: 2171 ± 755 mmHg/cm/s; p = 0.03), with no difference in the distal front velocity. A decrease in the integrative relaxation pressure of the lower esophageal sphincter (LES) was noted (OFF: 11.1 ± 1.8 mmHg vs ON: 7.2 ± 1.8 mmHg; p < 0.05) in ON. The LES resting pressure remained unchanged during the two periods. This resulted in a decrease in the intrabolus pressure (p = 0.03). No difference was observed for the upper esophageal sphincter, nor the pharyngeal contraction amplitude and velocity.

CONCLUSIONS & INFERENCES

In conclusion, STN stimulation in PD patients increased esophageal body contractions and enhanced the LES opening. This suggests that the nigrostriatal-striatonigral loop is involved in the control of esophageal motility.

© 2015 John Wiley & Sons Ltd.

Address: Nutrition, Gut & Brain Unit (INSERM UMR 1073), Institute for Biomedical Research and Innovation, Rouen University, Rouen, France.; Department of Neurosurgery, Rouen University Hospital, University of Rouen, Rouen, France.; Nutrition, Gut & Brain Unit (INSERM UMR 1073), Institute for Biomedical Research and Innovation, Rouen University, Rouen, France.; Department of Physiology, Rouen University Hospital, University of Rouen, Rouen, France.; Department of Neurology, Rouen University Hospital, University of Rouen, Rouen, France.; Department of Physiology, Rouen University Hospital, University of Rouen, Rouen, France.; Nutrition, Gut & Brain Unit (INSERM UMR 1073), Institute for Biomedical Research and Innovation, Rouen University, Rouen, France.; Department of Neurosurgery, Rouen University Hospital, University of Rouen, Rouen, France.; Department of Physiology, Rouen University Hospital, University of Rouen, Rouen, France.; Clinical Investigation Centre INSERM 0204, Rouen University Hospital, University of Rouen, Rouen, France.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.